SCHEMBL23923984

SCHEMBL23923984

C=C(CCC(CCC)CCCC)C(CCC)CCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.39
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 3/20 0.35
CHRM1 P11229 1/20 0.35
AKR1A1 P14550 1/20 0.35
CHRM3 P20309 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
MAPK1 P28482 1/20 0.35
CA1 P00915 4/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 3/20 0.33
CYP3A4 P08684 2/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31521517 0.84 CA2 (0.40) CA2ALDH1A1TDP1CHRM1AKR1A1
SCHEMBL31521573 0.84 CA2 (0.40) CA2ALDH1A1TDP1CHRM1AKR1A1
SCHEMBL23923711 0.83 CA2 (0.46) CA2ALDH1A1TDP1MAPK1CA1
SCHEMBL31521547 0.80 CA2 (0.42) CA2ALDH1A1TDP1MAPK1LMNA
SCHEMBL23923859 0.80 CA2 (0.42) CA2ALDH1A1TDP1MAPK1LMNA
SCHEMBL31521570 0.78 CA2 (0.42) CA2ALDH1A1TDP1HDAC1HDAC2
SCHEMBL31521540 0.77 CA2 (0.41) CA2ALDH1A1TDP1CHRM1AKR1A1
SCHEMBL31521492 0.76 CA2 (0.41) CA2ALDH1A1TDP1HDAC1HDAC2
SCHEMBL31521497 0.76 CA2 (0.41) CA2ALDH1A1TDP1HDAC1HDAC2
SCHEMBL23923680 0.76 ACE2 (0.38) CA2TDP1CHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US claimed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US claimed
WO-2025264609-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-12-26 WO disclosed
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2025-12-18 US disclosed
US-11174205-B2 C20 2-substituted alpha olefins produced by dimerization of branched C10 olefins CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2021-11-16 US disclosed
US-20210323892-A1 C20 2-Substituted Alpha Olefins Produced By Dimerization Of Branched C10 Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382242-A1 C20 TRISUBSTITUTED OLEFINS PRODUCED BY ACIDIC CATALYZED REACTION OF C20 2-SUBSTITUTED ALPHA OLEFINS COASY, MOGAT2, HSD17B12 CA2 1500/4885ALDH1A1 980/4885TDP1 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.